Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00658190 · ClinicalTrials.gov registry record
Internet-Based Cervical Cytology Screening Program
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 175
- Enrollment target
NCT00658190: Completed study, sponsored by Massachusetts General Hospital.
NCT00658190 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00658190 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether a system that couples automated screening of Pap Tests with transmission of machine selected digital images, and review by cytologists at a remote location, performs to a clinically effective standard of accuracy.
Primary Outcome
Identification of abnormalities compared to the initial interpretation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2003-10 |
| Est. Completion | 2013-01 |
What the finished NCT00658190 record still lists
NCT00658190 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00658190 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00658190 about?
NCT00658190 is a clinical study titled "Internet-Based Cervical Cytology Screening Program". The purpose of this study is to assess whether a system that couples automated screening of Pap Tests with transmission of machine selected digital images, and review by cytologists at a remote location, performs to a clinically effective standard of accuracy.
What is the current status of trial NCT00658190?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2003-10. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT00658190?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia